Trial Profile
Clinical Trials Insight: 700030190
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jan 2008
Price :
$35
*
At a glance
- Drugs Melogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Glenmark Pharmaceuticals Ltd
- 30 Jan 2008 New trial record.